Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetics of Parkinson's disease
Ajith Cherian, K. P. Divya
Acta Neurologica Belgica (2020) Vol. 120, Iss. 6, pp. 1297-1305
Closed Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Caterina Peggion, Tito Calì, Marisa Brini
Antioxidants (2024) Vol. 13, Iss. 2, pp. 240-240
Open Access | Times Cited: 25
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions
Stacey A. Sakowski, Emily J. Koubek, Kevin S. Chen, et al.
Annals of Neurology (2024) Vol. 95, Iss. 4, pp. 635-652
Open Access | Times Cited: 18
Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
Francesco Agostini, Anna Masato, Luigi Bubacco, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 398-398
Open Access | Times Cited: 63
Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
Noha Gouda, Ahmed Elkamhawy, Jungsook Cho
Biomedicines (2022) Vol. 10, Iss. 2, pp. 371-371
Open Access | Times Cited: 57
Parkinson's disease – genetic cause
Ajith Cherian, Divya K.P, Asish Vijayaraghavan
Current Opinion in Neurology (2023) Vol. 36, Iss. 4, pp. 292-301
Closed Access | Times Cited: 33
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis
Xiaoying Jiang, Kaiyu Wu, Xiang‐Yang Ye, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 872-896
Closed Access | Times Cited: 30
Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
Amica Corda Müller-Nedebock, Marieke C. J. Dekker, Matthew J. Farrer, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 10
The Potential Role of Mitochondria in the Microbiota-Gut-Brain Axis: Implications for Brain Health
Lei Qiao, Ge Yang, Peng Wang, et al.
Pharmacological Research (2024) Vol. 209, pp. 107434-107434
Open Access | Times Cited: 10
Regulation of mitophagy and mitochondrial function: Natural compounds as potential therapeutic strategies for Parkinson's disease
Hao Liang, Zhenwang Ma, Wei Zhong, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 1838-1862
Open Access | Times Cited: 8
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
A Practical Approach to Early-Onset Parkinsonism
Giulietta Riboldi, Emanuele Frattini, Edoardo Monfrini, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 1-26
Open Access | Times Cited: 45
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Sanne K. Meles, Wolfgang H. Oertel, Klaus L. Leenders
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 43
Long-noncoding RNAs as epigenetic regulators in neurodegenerative diseases
FrancescaLuisa Conforti, Paola Ruffo, Francesca De Amicis, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 6, pp. 1243-1243
Open Access | Times Cited: 35
Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration
Marianna D’Anca, Francesca R. Buccellato, Chiara Fenoglio, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4134-4134
Open Access | Times Cited: 34
Paraquat exposure induces Parkinsonism by altering lipid profile and evoking neuroinflammation in the midbrain
Tong Tong, Weixia Duan, Yu‐Dong Xu, et al.
Environment International (2022) Vol. 169, pp. 107512-107512
Open Access | Times Cited: 33
Neurological Insights into Sleep Disorders in Parkinson’s Disease
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1202-1202
Open Access | Times Cited: 22
Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up
Ilham Y. Abdi, Michael Bartl, Mohammed Dakna, et al.
Neurobiology of Disease (2023) Vol. 177, pp. 105997-105997
Open Access | Times Cited: 17
The brain on time: links between development and neurodegeneration
Khadijeh Shabani, Bassem A. Hassan
Development (2023) Vol. 150, Iss. 10
Open Access | Times Cited: 17
One-carbon epigenetics and redox biology of neurodegeneration
Fabio Coppedè
Free Radical Biology and Medicine (2020) Vol. 170, pp. 19-33
Closed Access | Times Cited: 43
A Multi-Trait Association Analysis of Brain Disorders and Platelet Traits Identifies Novel Susceptibility Loci for Major Depression, Alzheimer’s and Parkinson’s Disease
Alfonsina Tirozzi, Miriam Shasa Quiccione, Chiara Cerletti, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 245-245
Open Access | Times Cited: 14
Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases
Valentina La Cognata, Giovanna Morello, Sebastiano Cavallaro
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4820-4820
Open Access | Times Cited: 29
Predictors of RBD progression and conversion to synucleinopathies
Edoardo Rosario de Natale, Heather Wilson, Marios Politis
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 2, pp. 93-104
Open Access | Times Cited: 21
Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
Laura Smith, Chiao‐Yin Lee, Elisa Menozzi, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 21
Salsolinol as an RNA m6A methylation inducer mediates dopaminergic neuronal death by regulating YAP1 and autophagy
Jianan Wang, Yuanyuan Ran, Zihan Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 3, pp. 887-899
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top